Search

Your search keyword '"Kimura, G"' showing total 483 results

Search Constraints

Start Over You searched for: Author "Kimura, G" Remove constraint Author: "Kimura, G" Search Limiters Full Text Remove constraint Search Limiters: Full Text
483 results on '"Kimura, G"'

Search Results

1. Frontal Thrust Ramp‐Up and Slow Earthquakes Due To Underthrusting of Basement High in the Nankai Trough.

2. LDH isozyme as a prognostic factor for patients with metastatic clear cell renal cell carcinoma (mCRCC)

3. Prognostic significance of Serum Cytokeratin 19 Fragments (sCYFRA) in metastatic urothelial carcinoma patients treated with pembrolizumab

4. Site C0025

5. Site C0002

6. Expedition 358 summary

7. Expedition 358 methods

8. Site C0024

9. On the Assumption of Initial Factorization in the Master Equation for Weakly Coupled Systems I: General Framework

10. On the Assumption of Initial Factorization in the Master Equation for Weakly Coupled Systems II: Solvable Models

11. 154P Can urine cytology predict variants of bladder cancer?

15. Site C0010

16. Expedition 365 summary

17. Expedition 365 methods

19. Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer

20. How can we reduce the rate of incomplete resection in patients with non-muscle-invasive bladder cancer (NMIBC) undergoing first transurethral resection of bladder tumor (TURBT)? Impact of two-loop wide resection of surrounding tumor tissue

22. 708P PD-L1 as a predictor of survival in patients with metastatic urothelial carcinoma (mUC) from the phase III DANUBE trial of durvalumab (D) or durvalumab plus tremelimumab (D+T) versus standard of care chemotherapy (SoC)

29. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

30. 200O Pembrolizumab plus axitinib (pembro + axi) vs sunitinib in metastatic renal cell carcinoma (mRCC) outcomes of the KEYNOTE-426 study in patients from eastern Asia

31. Depth of oceanic-crust underplating in a subduction zone: inferences from fluid-inclusion analyses of crack-seal veins

32. Pseudotachylyte from an ancient accretionary complex: evidence for melt generation during seismic slip along a master decollement?

36. 729P Prognostic value of PD-L1 status in the primary lesion as a risk factor for developing metastatic disease in localized renal cell carcinoma: A subgroup analysis of the ARCHERY study

37. 725P Prognostic values of PD-L1 expression and CD8 infiltration phenotype in metastatic and recurrent renal cell carcinoma: An exploratory analysis of the ARCHERY study

38. Early therapeutic intervention improves radiation induced hemorrhagic cystitis and proctitis when treated with hyperbaric oxygen therapy

40. Investigation of Disintegration and Dissolution Behavior of Mefenamic Acid Drug Formulation Using Numeric Solution of Noyes-Whitney Equation with Cellular Automata Model on Microtomographic Surfaces and Rational Arrangements of Tablet Components

41. Well-preserved underplating structure of the jadeitized Franciscan complex, Pacheco Pass, California

50. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Catalog

Books, media, physical & digital resources